SEBIO 2015 Board of Directors

Officers:
Chair: Sue Washer, AGTC
Vice-Chair and Secretary: Todd Sherer, Emory University, Office of Technology Transfer
Treasurer: Mark Baxter, Ernst & Young
Ex Officio: Becky Kaufman, King & Spalding, LLP

Executive Committee:
Mark Baxter, Ernst & Young
William Brooke, Harbert Ventures Partners
Becky Kaufman, King & Spalding LLP
Todd Sherer, Ph.D., Emory University, Office of Technology Transfer
Ken Tindall, Ph.D., North Carolina Biotechnology Center
Sue Washer, AGTC
Dave Winwood, Pennington Biomedical Research Center

Directors:
Brian Adams, Ph.D., Arbor Pharmaceuticals, Inc.
Russell Allen, Georgia Bio
Ali Behbahani, NEA
Gerry Brunk, Lumira Capital
Nancy Bryan, BioFlorida
Tom Callaway, M.D., HealthQuest Capital
Suzanne Cantando, Southeast BIO
David L. Day, University of Florida, Office of Technology Licensing
Jeff Gallagher, Virginia Biotechnology Association
Tim Gupton, Hughes Pittman & Gupton, LLP
Mike Gutch, Ph.D., AstraZeneca
Steve Hall, Lilly Ventures
Frank Hunt, PNP Therapeutics, Inc.
Mara Huntington, Square 1 Bank
Garheng Kong, HealthQuest Capital
Sharon Krueger, University of Virginia, Office of the VP for Research
Scott McCarty, Silicon Valley Bank
Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Kathy Nugent, PhD, BioAlabama
Dan O’Korn, Hutchison Law Group, PLLC
Doug Reed, Hatteras Venture Partners
Rose Ritts, Ph.D., Duke University, Office of Licensing & Ventures
Larry Robbins, Wyrick Robbins Yates & Ponton, LLP
Wayne Roper, SCBIO
James Rosen, Bill & Melinda Gates Foundation
Susan Shows, Georgia Research Alliance
Abby Trotter, Life Science Tennessee
Geeta Vemuri, Baxter Healthcare Corporation
Richard West
Miriam Wilson, Council for Entrepreneurial Development (CED)
Ford Worthy, Pappas Ventures
Karen Zederej, AxoGen, Inc.